Not All Inhaled Medicines Are Equal
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Current Perspectives of Pharmacotherapies for COPD.
Pleasants R, Donohue J Respir Care. 2023; 68(7):927-938.
PMID: 37353337 PMC: 10289617. DOI: 10.4187/respcare.10952.
References
1.
Dekhuijzen P, Batsiou M, Bjermer L, Bosnic-Anticevich S, Chrystyn H, Papi A
. Incidence of oral thrush in patients with COPD prescribed inhaled corticosteroids: Effect of drug, dose, and device. Respir Med. 2016; 120:54-63.
DOI: 10.1016/j.rmed.2016.09.015.
View
2.
Braman S, Carlin B, Hanania N, Mahler D, Ohar J, Pinto-Plata V
. Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPD. Respir Care. 2018; 63(7):840-848.
DOI: 10.4187/respcare.05717.
View
3.
Rabin A, Harlan E, Ambinder A
. Small Devices, Big Problems: Addressing the Global Warming Potential of Metered-Dose Inhalers. Ann Am Thorac Soc. 2022; 19(7):1090-1092.
DOI: 10.1513/AnnalsATS.202202-131VP.
View
4.
Kachroo P, Stewart I, Kelly R, Stav M, Mendez K, Dahlin A
. Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma. Nat Med. 2022; 28(4):814-822.
PMC: 9350737.
DOI: 10.1038/s41591-022-01714-5.
View